SWS Academic Research eLibraryEarth & Planetary Sciences

Scholarly record

INTERMOLECULAR INTERACTIONS IN BIOPOLYMER COMPOSITES STUDIED BY IR SPECTROSCOPY

Voycheva, Christina, Dimitrov, Milen, Petkova, Valentina, Georgiev, Vassil, Natova, Margarita, Baranovsky, . Vladimir

First published: 2013-06-20https://doi.org/10.5593/sgem2013/bf6/s25.014View metrics

Publication Impact Profile

PlumX
  • Captures
  • Mendeley - Readers: 3
PLUMX see details

Publication details

Title
INTERMOLECULAR INTERACTIONS IN BIOPOLYMER COMPOSITES STUDIED BY IR SPECTROSCOPY
Authors
Voycheva, Christina, Dimitrov, Milen, Petkova, Valentina, Georgiev, Vassil, Natova, Margarita, Baranovsky, . Vladimir
Proceedings
SGEM International Multidisciplinary Scientific GeoConference EXPO Proceedings; 13th SGEM GeoConference NANO, BIO AND GREEN TECHNOLOGIES FOR A SUSTAINABLE FUTURE
Publisher
Stef92 Technology
Year
2013
Pages
169 - 176 pp
ISSN
1314-2704
ISBN
Not available yet
Language
en
Publication type
Conference Paper
References48

  1. Current technologies to increase the transdermal delivery of drugs, Eds. Escobar- Chávez J. J. & Merino V., Universidad Nacional Autonoma de Mexico, Mexico, Bentham Science Publishers, 2010.

  2. Moustafine R. I., Kemenova V. A. & Van den Mooter G. Characteristics of interpolyelectrolyte complexes of Eudragit E 100 with sodium alginate, International Journal of Pharmaceutics vol. 294, pp. 113– 120, 2005.

  3. Moustafine R. I., Zaharov I. M. & Kemenova V. A. Physicochemical characterization and drug release properties of Eudragitw E PO/Eudragitw L 100-55 interpolyelectrolyte complexes, European Journal of Pharmaceutics and Biopharmaceutics, vol. 63, pp. 26– 36, 2006.

  4. Gums and Stabilisers for the Food Industry 13, Eds. Williams P. A. & Phillips G. O., RSC Publishing, 2006.

  5. Gayet J.C. & Fortier G. High water content BSA-PEG hydrogel for controlled release device: evaluation of the drug release properties, J. Control. Release, vol. /issue 2-3, pp. 177–184, 1996.

  6. V.R. Sinha & L. Khosla, Bioabsorbable polymers for implantable therapeutic systems, Drug Dev. Ind. Pharm., vol. 24/issue12, pp. 1129–1138, 1998.

  7. Beyssac E., Bregni C., Aiache J.M., Gerula S. & Smolko E. Hydrogel implants for methotrexate obtained by ionizing radiation, Drug Dev. Ind. Pharm., vol. 22/issue 5, pp. 439–444, 1996.

  8. Teijon J.M., Trigo R.M., García O. & Blanco M.D. Cytarabine trapping in poly(2- hydroxyethyl methacrylate) hydrogels: drug delivery studies, Biomaterials, vol. 18/issue 5, pp. 383–388, 1997.

  9. Blanco M.D., Gomez C., arc a O. Teijon J.M. Ara-C release from poly(acrylamide- co-monomethyl itaconate) hydrogels: in vitro and in vivo studies, Polym. Gels Netw., vol. 6/issue 1, pp. 57–69, 1998.

  10. Kuzma P., Moo-Young A.J., Mora D., Quandt H., Bardin C.W. & Schlegel P.H. Subcutaneous hydrogel reservoir system for controlled drug delivery, Macromol. Symp., vol. 109/issue 1, pp. 15–26, 1996.

  11. Dobrynin A.V., Colby A.H. & Rubinstein M. Polyampholytes, J. Polym. Sci. Part B, vol. 42/issue 19, pp. 3513– 3538, 2004. GeoConference on Nano, Bio and Green – Technologies for a Sustainable Future

  12. Alasino R. V., Leonhard V., Bianco I. D. & Beltramo D. M. Eudragit E100 surface activity and lipid interaction, Colloids and Surfaces B: Biointerfaces, vol. 91, pp. 84 – 89, 2012.

  13. Aguzzi C., Capra P., Bonferoni C., Cerezo P., Salcedo I., Sanchez R., Caramella C. & Viseras C. Chitosan –silicate biocomposites to be used in modified drug release of 5- aminosalicylic acid (5-ASA), Appl. Clay Sci., vol. 50/issue 1, pp. 106–111, 2010.

  14. Kevadiya B.D., Patel H.A., Joshi G.V., Abdi S.H.R. & Bajaj H.C. Montmorillonite-Alginate composites as a drug delivery system: intercalation and in vit ro release of diclofenac sodium, Indian J. Pharm. Sci., vol. 72/issue 6, pp. 732 –737, 2011.

  15. Ha J.U. & Xanthos M. Drug release characteristics from nanoclay hybrids and their dispersions in organic polymers, Int. J. Pharmaceut., vol. 414/issue 1-2, pp. 321 –331, 2011.

  16. Alasino R.V., Ausar S.F., Bianco I.D., Castagna L.F., Contigiani M. & Beltramo D.M. Amphipathic and Membrane-Destabilizing Properties of the Cationic Acrylate Polymer Eudragit® E100, Macromol. Biosci., vol. 5/issue 3, pp. 207-213, 2005.

  17. Alasino R.V., Bianco I.D., Vitali M.S., Zarzur J.A. & Beltramo D.M. Characterization of the inhibition of enveloped virus infectivity by the cationic acrylate polymer Eudragit E100, Macromol. Biosci., vol. 7/issue 9-10, pp. 1132– 1138, 2007.

  18. Ward C.J., Song S. & Davis E.W. Controlled release of tetracycline-HCl from halloysite-polymer composite films, J. Nanosci. Nanotechnol., vol. 10/issue 10, pp. 6641–6649, 2010.

  19. Saerens L., Dierickx L., Lenain B., Vervaet C., Remon J. P. & De Beer T. Raman spectroscopy for the in-line polymer-drug quantification and solid state characterization during a pharmaceutical hot-melt extrusion process, Eur. J. of Pharmaceutics and Biopharmaceutics, vol. 77/issue 1, pp. 158– 163, 2011.

  20. He Y., Zhu B. & Inoue Y. Hydrogen bonds in polymer blends, Prog. Polym. Sci., vol. 29/issue 10, pp. 1021– 1051, 2004.

  21. Seremeta K. P., Chiappetta D. A. Sosnik A. Poly(ε -caprolactone), Eudragit® RS 100 and poly(ε -caprolactone)/Eudragit® RS 100 blend submicron particles for the sustained release of the antiretroviral Efavirenz, Colloids and Surfaces B: Biointerfaces, vol. 102, pp. 441– 449, 2013.

  22. Boeris V., Micheletto Y., Lionzo M., Pesce da Silveira N. & Picó G. Interaction behavior between chitosan and pepsin, Carbohydrate Polymers, vol. 84/issue 1, pp. 459–464, 2011.

  23. Li J., Jiang Z., Wu H., Liang Y., Zhang Y. & Liu J. Enzyme –polysaccharide interaction and its influence on enzyme activity and stability. Carbohydrate Polymers, vol. 82/issue 1, pp. 160– 166, 2010.

  24. Subramanian A., Rau A. V. & Kaligotla H. Surface modification of chitosan for selective surface–protein interaction. Carbohydrate Polymers, vol. 66/issue 3, pp. 321 – 332, 2006.

  25. Current technologies to increase the transdermal delivery of drugs, Eds. Escobar- Chávez J. J. & Merino V., Universidad Nacional Autonoma de Mexico, Mexico, Bentham Science Publishers, 2010.

  26. Moustafine R. I., Kemenova V. A. & Van den Mooter G. Characteristics of interpolyelectrolyte complexes of Eudragit E 100 with sodium alginate, International Journal of Pharmaceutics vol. 294, pp. 113– 120, 2005.

  27. Moustafine R. I., Zaharov I. M. & Kemenova V. A. Physicochemical characterization and drug release properties of Eudragitw E PO/Eudragitw L 100-55 interpolyelectrolyte complexes, European Journal of Pharmaceutics and Biopharmaceutics, vol. 63, pp. 26– 36, 2006.

  28. Gums and Stabilisers for the Food Industry 13, Eds. Williams P. A. & Phillips G. O., RSC Publishing, 2006.

  29. Gayet J.C. & Fortier G. High water content BSA-PEG hydrogel for controlled release device: evaluation of the drug release properties, J. Control. Release, vol. /issue 2-3, pp. 177–184, 1996.

  30. V.R. Sinha & L. Khosla, Bioabsorbable polymers for implantable therapeutic systems, Drug Dev. Ind. Pharm., vol. 24/issue12, pp. 1129–1138, 1998.

  31. Beyssac E., Bregni C., Aiache J.M., Gerula S. & Smolko E. Hydrogel implants for methotrexate obtained by ionizing radiation, Drug Dev. Ind. Pharm., vol. 22/issue 5, pp. 439–444, 1996.

  32. Teijon J.M., Trigo R.M., García O. & Blanco M.D. Cytarabine trapping in poly(2- hydroxyethyl methacrylate) hydrogels: drug delivery studies, Biomaterials, vol. 18/issue 5, pp. 383–388, 1997.

  33. Blanco M.D., Gomez C., arc a O. Teijon J.M. Ara-C release from poly(acrylamide- co-monomethyl itaconate) hydrogels: in vitro and in vivo studies, Polym. Gels Netw., vol. 6/issue 1, pp. 57–69, 1998.

  34. Kuzma P., Moo-Young A.J., Mora D., Quandt H., Bardin C.W. & Schlegel P.H. Subcutaneous hydrogel reservoir system for controlled drug delivery, Macromol. Symp., vol. 109/issue 1, pp. 15–26, 1996.

  35. Dobrynin A.V., Colby A.H. & Rubinstein M. Polyampholytes, J. Polym. Sci. Part B, vol. 42/issue 19, pp. 3513– 3538, 2004. GeoConference on Nano, Bio and Green – Technologies for a Sustainable Future

  36. Alasino R. V., Leonhard V., Bianco I. D. & Beltramo D. M. Eudragit E100 surface activity and lipid interaction, Colloids and Surfaces B: Biointerfaces, vol. 91, pp. 84 – 89, 2012.

  37. Aguzzi C., Capra P., Bonferoni C., Cerezo P., Salcedo I., Sanchez R., Caramella C. & Viseras C. Chitosan –silicate biocomposites to be used in modified drug release of 5- aminosalicylic acid (5-ASA), Appl. Clay Sci., vol. 50/issue 1, pp. 106–111, 2010.

  38. Kevadiya B.D., Patel H.A., Joshi G.V., Abdi S.H.R. & Bajaj H.C. Montmorillonite-Alginate composites as a drug delivery system: intercalation and in vit ro release of diclofenac sodium, Indian J. Pharm. Sci., vol. 72/issue 6, pp. 732 –737, 2011.

  39. Ha J.U. & Xanthos M. Drug release characteristics from nanoclay hybrids and their dispersions in organic polymers, Int. J. Pharmaceut., vol. 414/issue 1-2, pp. 321 –331, 2011.

  40. Alasino R.V., Ausar S.F., Bianco I.D., Castagna L.F., Contigiani M. & Beltramo D.M. Amphipathic and Membrane-Destabilizing Properties of the Cationic Acrylate Polymer Eudragit® E100, Macromol. Biosci., vol. 5/issue 3, pp. 207-213, 2005.

  41. Alasino R.V., Bianco I.D., Vitali M.S., Zarzur J.A. & Beltramo D.M. Characterization of the inhibition of enveloped virus infectivity by the cationic acrylate polymer Eudragit E100, Macromol. Biosci., vol. 7/issue 9-10, pp. 1132– 1138, 2007.

  42. Ward C.J., Song S. & Davis E.W. Controlled release of tetracycline-HCl from halloysite-polymer composite films, J. Nanosci. Nanotechnol., vol. 10/issue 10, pp. 6641–6649, 2010.

  43. Saerens L., Dierickx L., Lenain B., Vervaet C., Remon J. P. & De Beer T. Raman spectroscopy for the in-line polymer-drug quantification and solid state characterization during a pharmaceutical hot-melt extrusion process, Eur. J. of Pharmaceutics and Biopharmaceutics, vol. 77/issue 1, pp. 158– 163, 2011.

  44. He Y., Zhu B. & Inoue Y. Hydrogen bonds in polymer blends, Prog. Polym. Sci., vol. 29/issue 10, pp. 1021– 1051, 2004.

  45. Seremeta K. P., Chiappetta D. A. Sosnik A. Poly(ε -caprolactone), Eudragit® RS 100 and poly(ε -caprolactone)/Eudragit® RS 100 blend submicron particles for the sustained release of the antiretroviral Efavirenz, Colloids and Surfaces B: Biointerfaces, vol. 102, pp. 441– 449, 2013.

  46. Boeris V., Micheletto Y., Lionzo M., Pesce da Silveira N. & Picó G. Interaction behavior between chitosan and pepsin, Carbohydrate Polymers, vol. 84/issue 1, pp. 459–464, 2011.

  47. Li J., Jiang Z., Wu H., Liang Y., Zhang Y. & Liu J. Enzyme –polysaccharide interaction and its influence on enzyme activity and stability. Carbohydrate Polymers, vol. 82/issue 1, pp. 160– 166, 2010.

  48. Subramanian A., Rau A. V. & Kaligotla H. Surface modification of chitosan for selective surface–protein interaction. Carbohydrate Polymers, vol. 66/issue 3, pp. 321 – 332, 2006.

View or Download full articleAccess options
Full paper accessChoose SWS login, librarian support, or instant article download.

SWS access login

Login as SWS Scientific Committee

Authors and approved SWS contributors will read and export their own linked papers after identity matching by SWS profile, email and SGEM GlobalID.

For librarian assistance: [email protected]

Purchase Instant Access

48-hour online accessComing soon
Online-only accessComing soon
Download the full article in PDF formatEUR 35
  • Article can be downloaded after successful payment.
  • Article may be used according to SWS library access terms.
  • Article cannot be redistributed.
Get full paper

Back to publication list